Extracellular matrix of central nervous system white matter: demonstration of an hyaluronate-protein complex.
Monoclonal antibodies were raised against human glial hyaluronate-binding protein (GHAP), a major CNS-specific glycoprotein known to bind hyaluronate in vitro. Frozen sections of dog and human spinal cord were digested with Streptomyces hyaluronidase in order to ascertain whether GHAP is bound to hyaluronate in vivo. Digestion with hyaluronidase, prior to staining of the sections by conventional indirect immunofluorescence, led to a drastic reduction in the intensity of the staining reaction. Chondroitinase ABC (protease-free) was also effective in bringing about the release of GHAP from tissue sections. This enzyme also degrades hyaluronate. The effects of the chondroitinase were completely reversed by the addition of 1 mM Zn2+, a known inhibitor of this enzyme. The intact protein was released into the soluble fraction of human brain homogenates by testicular hyaluronidase. An immunoreactive species of 70 kD was released into the soluble fraction of dog spinal cord homogenates by Streptomyces hyaluronidase. Dog GHAP was isolated from spinal cord by means of ion exchange and affinity chromatography. This protein bound efficiently to hyaluronate in vitro. Dog and human GHAP had identical isoelectric points and similar peptide maps but different molecular weights. Dog GHAP (70 kD) was larger than its human counterpart (60 kD). These findings imply that GHAP exists in association with hyaluronate in CNS white matter. Immunoelectron microscopy revealed that GHAP fills the space between myelin sheaths in dog spinal cord white matter. One is led to conclude therefore that an hyaluronate based extracellular matrix exists in CNS white matter.
Asher
R
R
Department of Pathology, Harvard Medical School, Boston, Massachusetts.
Perides
G
G
Vanderhaeghen
J J
JJ
Bignami
A
A
D000581:Amidohydrolases / Q000494:pharmacology; D000818:Animals; D000911:Antibodies, Monoclonal; D015415:Biomarkers; D002352:Carrier Proteins / Q000032:analysis* / Q000276:immunology; D002417:Cattle; D002808:Chondroitin Lyases / Q000494:pharmacology; D005109:Extracellular Matrix / Q000737:chemistry*; D005260:Female; D006801:Humans; D018960:Hyaluronan Receptors; D006820:Hyaluronic Acid / Q000378:metabolism*; D006821:Hyaluronoglucosaminidase / Q000494:pharmacology; D051379:Mice; D008807:Mice, Inbred BALB C; D043524:Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase; D013116:Spinal Cord / Q000737:chemistry* / Q000187:drug effects
D000911:Antibodies, Monoclonal; D015415:Biomarkers; D002352:Carrier Proteins; D018960:Hyaluronan Receptors; D006820:Hyaluronic Acid; D006821:Hyaluronoglucosaminidase; D000581:Amidohydrolases; D043524:Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase; D002808:Chondroitin Lyases